ReNeuron Group PLC
LSE:RENE
ReNeuron Group PLC
Net Income (Common)
ReNeuron Group PLC
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
R
|
ReNeuron Group PLC
LSE:RENE
|
Net Income (Common)
-£5.1m
|
CAGR 3-Years
30%
|
CAGR 5-Years
18%
|
CAGR 10-Years
3%
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Net Income (Common)
-$151.1m
|
CAGR 3-Years
-142%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Net Income (Common)
-$208.4m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Net Income (Common)
-$168.2m
|
CAGR 3-Years
-44%
|
CAGR 5-Years
-45%
|
CAGR 10-Years
N/A
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Net Income (Common)
-£55.3m
|
CAGR 3-Years
9%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
Genus PLC
LSE:GNS
|
Net Income (Common)
£33.4m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
3%
|
See Also
What is ReNeuron Group PLC's Net Income (Common)?
Net Income (Common)
-5.1m
GBP
Based on the financial report for Sep 30, 2023, ReNeuron Group PLC's Net Income (Common) amounts to -5.1m GBP.
What is ReNeuron Group PLC's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
3%
Over the last year, the Net Income (Common) growth was 34%. The average annual Net Income (Common) growth rates for ReNeuron Group PLC have been 30% over the past three years , 18% over the past five years , and 3% over the past ten years .